par 143 par 143 (Hydralazine hydrochloride and hydrochlorothiazide 25 mg / 25 mg)
Pill with imprint par 143 par 143 is White, Capsule-shape and has been identified as Hydralazine hydrochloride and hydrochlorothiazide 25 mg / 25 mg. It is supplied by Par Pharmaceutical Inc..
Hydralazine/hydrochlorothiazide is used in the treatment of high blood pressure; heart failure and belongs to the drug class miscellaneous antihypertensive combinations. Risk cannot be ruled out during pregnancy. Hydralazine/hydrochlorothiazide 25 mg / 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for par 143 par 143
- par 143 par 143
- 25 mg / 25 mg
- Prescription only
- Drug Class:
- Miscellaneous antihypertensive combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Par Pharmaceutical Inc.
- National Drug Code (NDC):
More about hydralazine/hydrochlorothiazide
- Hydralazine/hydrochlorothiazide Side Effects
- During Pregnancy
- Drug Images
- Drug Interactions
- Support Group
- 0 Reviews – Add your own review/rating
- Drug class: miscellaneous antihypertensive combinations
Other brands: Apresazide
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.